FindMyKOL

Manisha Shah, MD

Enriched profile

Associate Professor of Internal Medicine · The Ohio State University Medical Center

ORCIDNone on fileNPI↗
✓ Itemized profile
Region🇺🇸 Columbus, OH · Midwest · United StatesSpecialtyMedical OncologyFocusCarcinoid Tumor+13
Last active 2020FindMyKOL type: RegionalLatest publicationNone indexedOnline presenceNone verifiedPaymentsNone reportedNIH funding2002–2020Why? →

Manisha Shah is Associate Professor of Internal Medicine at The Ohio State University Medical Center. ClinicalTrials.gov lists 10 registered studies with this person as an investigator.

Data verified 12 Nov 2026

Overview

Updated 17 Nov 2026

Manisha Shah, M.D., is Associate Professor of Internal Medicine at The Ohio State University Medical Center. It also documents an investigator role on 10 registered clinical trials, 3 NIH-funded awards (2002–2020).

  • Top research focus: Carcinoid Tumor
  • 10 registered trials on ClinicalTrials.gov

Generated from the cited public record · current as of 17 Nov 2026. Every fact links its source below.

Indications focus

from trials led + research topics
Carcinoid Tumor2 trialsGastroesophageal Cancer2 trialsStomach Neoplasms2 trialsThyroid cancer, follicular2 trialsThyroid Cancer, Papillary2 trialsAdenoma, Islet Cell1 trialCarcinoma, Islet Cell1 trialCarcinoma, Medullary1 trialCarcinoma, Papillary1 trialGastrinoma1 trialGlucagonoma1 trialHead & Neck Cancer1 trialInsulinoma1 trialSomatostatinoma1 trial

Research focus

OpenAlex concept fingerprint
Carcinoid TumorGastroesophageal CancerStomach NeoplasmsThyroid Cancer, PapillaryThyroid cancer, follicularAdenoma, Islet CellCarcinoma, Islet CellCarcinoma, MedullaryCarcinoma, PapillaryGastrinomaGlucagonomaHead & Neck CancerInsulinomaSomatostatinoma

Works with

trial sponsors and companies reporting payments
National Cancer Institute (NCI)Clinical trials7Industry payments—Ohio State University Comprehensive Cancer CenterClinical trials2Industry payments—Manisha ShahClinical trials1Industry payments—

Scholarship

indexed output and impact (OpenAlex)
View publications ↓

Research metrics need a complete publication history and a confident author match. We omit them when either check fails. Why? →

Clinical & industry

trials, payments and federal funding
10clinical trials

Investigator role on registered studies.

View trials ↓
0companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓
3NIH grants · 2002–2020

Federally funded research awards.

View funding ↓

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 12 Nov 2026

Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

No payments involving this person were reported to CMS in program years 2021–2024. Why? →

Medicare prescribing footprint (2021)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Metabolism & gastrointestinal

    69.2%
    Antidiarrheal38.5%
    Diphenoxylate-Atropine100%
    Part D<11 patients
    Corticosteroid30.8%
    Prednisone100%
    Part D<11 patients
  • Cancer & immunology

    30.8%
    Kinase inhibitor30.8%
    Lenvima100%
    Part D<11 patients
Where care is delivered (Part B)0% facility · 100% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 12 Nov 2026

3 NIH research awards on record, funded 2002–2020 per NIH RePORTER. The latest:

Publications

None on file yet. We only list publications we can confidently match to this person. Why? →

Online presence

Updated 12 Nov 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    convenehealthcare.com/specialists/profile/dr-manisha-shah-columbus

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →convenehealthcare.com ↗
  • Other

    medifind.com/doctors/manisha-shah/7526675

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →medifind.com ↗

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 12 Nov 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →healthgrades.com ↗

Media & interviews

press, podcasts and appearances

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.